Skip to main content

Retinitis Pigmentosa 39 clinical trials at UCSF
1 in progress, 1 open to new patients

  • Rate of Progression in USH2A Related Retinal Degeneration

    open to eligible people ages 8 years and up

    The overall goal of this project is to characterize the natural history of disease progression in patients with USH2A related retinal degeneration associated with congenital hearing loss (Usher syndrome type 2a) or non-syndromic retinitis pigmentosa (RP39).

    San Francisco, California and other locations